Hyundai Motor has included Samsung SDI among the final candidates that would supply batteries for its electric vehicles set for release in 2023.
The largest South Korean carmaker is looking for a supplier for the third batch of batteries for its E-GMP platform -based EVs.
Designed by Hyundai Motor, the E-GMP platform is for EVs that load batteries under tits floor instead of the engine bay.
The selected partners will supply batteries worth 25 trillion won to Hyundai Motor’s electric SUV Ioniq 7.
The deal could become the first EV battery supply contract between Hyundai Motor and Samsung SDI.
The first batch of batteries worth 10 trillion won to be loaded this year on Hyundai’s E-GMP-based EVs will come from SK Innovation. The second batch worth 16 trillion won will be supplied exclusively by LG Energy Solution and China’s CATL.


China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds
Rio Tinto–Glencore Talks Spark Pressure on BHP as Copper Fuels Mining Mega Deals
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
xAI Cash Burn Highlights the High Cost of Competing in Generative AI
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 



